发明名称 |
Xrcc3 is required for assembly of Rad51-complexes in vivo |
摘要 |
The present invention relates to the interaction of Rad51 and Xrcc3 to form a complex that mediates DNA repair in eukaryotic cells. A functional Rad51/Xrcc3 complex can be introduced into a cell to increase the resistance of the cell to DNA damaging agents. The invention also provides for a clinical application of a regimen combining Rad51 and Xrcc3 to reduce the side effects of radiotherapy and chemotherapy in a patient. In addition, the invention discloses methods for identifying candidate substances that interact with the Rad51/Xrcc3 complex. In another embodiment of the invention, preventing the formation of the Rad51/Xrcc3 complex increases the susceptibility of a cell to DNA damaging agents. This strategy can be used in combination with a DNA damaging agent or factor to kill cancerous cells.
|
申请公布号 |
US2001036929(A1) |
申请公布日期 |
2001.11.01 |
申请号 |
US20010844538 |
申请日期 |
2001.04.26 |
申请人 |
ARCH DEVELOPMENT CORPORATION. |
发明人 |
WEICHSELBAUM RALPH R.;BISHOP DOUGLAS K. |
分类号 |
A61K33/24;A61K38/00;A61K48/00;C07K14/47;(IPC1-7):A61K48/00 |
主分类号 |
A61K33/24 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|